fusaric acid has been researched along with Escherichia coli Infections in 1 studies
Fusaric Acid: A picolinic acid derivative isolated from various Fusarium species. It has been proposed for a variety of therapeutic applications but is primarily used as a research tool. Its mechanisms of action are poorly understood. It probably inhibits DOPAMINE BETA-HYDROXYLASE, the enzyme that converts dopamine to norepinephrine. It may also have other actions, including the inhibition of cell proliferation and DNA synthesis.
Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khachatryan, AR | 1 |
| Hancock, DD | 1 |
| Besser, TE | 1 |
| Call, DR | 1 |
1 other study available for fusaric acid and Escherichia coli Infections
| Article | Year |
|---|---|
Antimicrobial drug resistance genes do not convey a secondary fitness advantage to calf-adapted Escherichia coli.
Topics: Aging; Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Culture Media; Dairying; Drug Resist | 2006 |